Genius Sports Limited

Genius Sports Limited Q3 2026 Earnings Recap

GENI Q3 2026 Published November 8, 2026

Get alerts when GENI reports next quarter

Set up alerts — free

Genius Sports shares fell 14.8% despite Q3 revenue and adjusted EBITDA topping the company’s guidance. The transcript offers no explicit guidance cut or outlook warning; the likely source of investor disappointment is that the reported beat and cash-flow progress did not establish stronger forward growth, while management’s prediction-market opportunity remains largely prospective.

Earnings Per Share Miss
$-0.06 vs $0.01 est.
-722.4% surprise
Revenue Beat
269864000 vs 261128000 est.
+3.3% surprise

Market Reaction

Post-Earnings -14.84%

See GENI alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Revenue was $270 million, above company guidance of $260 million; adjusted EBITDA was $87 million versus guidance of $85 million.
  • Adjusted EBITDA margin was 32%, up 12 percentage points year over year. Free cash flow was $54 million, equal to 61% of adjusted EBITDA.
  • Betting revenue increased 33% year over year. Management said 70%–80% of betting revenue comes from contractually fixed minimum guarantees.
  • Management cited nearly 60% year-over-year growth in NFL gross gaming revenue and nearly 50% growth in in-play GGR over the first four weeks of the season; the quarter included only three NFL weeks.
  • Prediction markets are a major strategic focus, but the opportunity described is still developing: Genius said it had added more than 50 customers this year and highlighted monetization across customer acquisition, trading data, and settlement.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit GENI on AllInvestView.

Get the Full Picture on GENI

Track Genius Sports Limited in your portfolio with real-time analytics, dividend tracking, and more.

View GENI Analysis